Abstract A wide variety of herbal remedies are used in traditional African medicine to treat inflammatory disorders, including some autoimmune diseases. Thirty-four extracts from 13 South African plant species traditionally used for the treatment of inflammation were investigated for their ability to control a microbial trigger for ankylosing spondylitis (Klebsiella pneumoniae). Twenty-six of the extracts (76.5 %) inhibited the growth of K. pneumoniae. Methanol and water extracts of Ballota africana, Carpobrotus edulis leaves, Kigellia africana, Lippia javanica, Pelargonium fasiculata, Syzygium cordatum (including bark), Terminalia pruinoides and Terminalia sericea were effective K. pneumoniae inhibitors, with MIC values\1000 lg/ml. The roots of Tulbaghia violaceae and bark from Warburgia salutaris also demonstrated efficacy. The most potent extracts were examined by RP-HPLC and UV-Vis spectroscopy for the presence of resveratrol. Methanolic extracts of B. africana, C. edulis leaves, L. javanica, T. pruinoides and T. sericea, as well as aqueous B. africana, T. pruinoides and T. sericea extracts, displayed peaks with retention times and UV-Vis spectra consistent with the presence of resveratrol. Resveratrol was generally a minor component, indicating that resveratrol was not solely responsible for the anti-Klebsiella growth inhibitory properties. Plant extracts with K. pneumoniae inhibitory activity were either non-toxic, or of low toxicity in the Artemia (brine shrimp) nauplii bioassay. Their low toxicity and antibiotic bioactivity against K. pneumoniae indicate their potential for both preventing the onset of ankylosing spondylitis and minimising its symptoms once the disease is established.
Introduction
Auto-immune inflammatory disorders (AIID's) are a group of debilitating conditions including rheumatoid arthritis, ankylosing spondylitis and lupus, which afflict genetically susceptible individuals. There is no common susceptibility profile for these disorders. Rheumatoid arthritis for example is most prevalent in middle aged to older women, whereas the onset of ankylosing spondylitis occurs most frequently in younger males (Lawrence et al. 1998 ). There are currently no cures for any of these conditions, so there is an urgent need to develop effective treatments which will not only alleviate the symptoms but also prevent the disease onset and progression.
Ankylosing spondylitis (AS) is a form of chronic inflammatory arthritis which mainly affects the spinal joints and large synovial joints such as the sacroiliac joint in the pelvis. AS afflicts up to 0.9 % of the world's population (Rashid and Ebringer 2007) and accounts for 0.5-1.9 % of all types of spondyloarthritis [a similar prevalence to that of rheumatoid arthritis (RA)] (Braun et al. 1998 ). In contrast to RA which afflicts approximately three times as many women as men (Lawrence et al. 1998) , AS has a significantly greater incidence in males (Rashid and Ebringer 2007) . Also in contrast with RA, where onset generally occurs in middle to old age, the onset of AS predominantly occurs in the second and third decades of life (Braun and Sieper 2007; Rashid and Ebringer 2007) . AS is characterised by spinal stiffness associated with inflammation and chronic back pain, which is often also referred to the buttocks and/or the back of the thigh. The disease may produce only mild to moderate symptoms in some individuals. In many sufferers it produces severe, disabling pain with substantial loss of function and mobility if not adequately treated. The chronic inflammation associated with AS often causes the formation of bridging syndesmophytes on the vertebrae due to ossification of the annulus fibrosis. These syndesmophytes may bridge the vertebrae and fuse them together, leading to the formation of 'bamboo spine'.
There is currently no known cure for AS. Current treatment strategies aim to either alleviate the symptoms (particularly pain and local tissue swelling) with analgesics and anti-inflammatory agents and/or the use of disease modifying anti-rheumatic drugs (DMARDs). Alternatively, AS may be controlled through the use of biological therapies such as anti-tumour necrosis factor therapy (Braun et al. 2005) . None of the current pharmacological treatments are ideal as prolonged usage of these drugs is often accompanied by significant side effects and toxicity (Alataha et al. 2003) . In severe cases of AS, surgery to replace joints (particularly hip and knee joints) may also be required. Whilst surgical procedures are also available to repair spinal fusions, this is considered so risky that it is rarely considered except for very severe cases of spinal curvature (Braun et al. 2011) . There is a need to find and develop safe, effective drugs for the treatment of AS which will not only alleviate the symptoms, but which might also cure (or prevent) the disease. Greater understanding of the disease's aetiology and progression should allow more relevant drug discovery and development.
AS is generally accepted to be an autoimmune disorder which may be triggered by specific microbial infections in genetically susceptible individuals (individuals with the MHC class 1 allele HLA-B27) (Rashid and Ebringer 2007) . Klebsiella pneumoniae has been suggested as a possible trigger for the pathogenesis of AS based on several lines of evidence:
• Many studies have documented the presence of elevated serum levels of antibodies specific to K. pneumoniae in individuals suffering from AS (Ebringer et al. 2006; Blankenberg-Sprenkels et al. 1998; Chou and Uksila 1998; Maki-Ikola et al. 1997; Tani et al. 1997; Tiwana et al. 1997 ).
• Sera from rabbits immunised with HLA-B27 reacted significantly with Klebsiella spp. (Welsh et al. 1980 ). • Sera from Klebsiella-immunised rabbits were able to distinguish between HLA-B27 positive lymphocytes from either AS patients or healthy controls and HLA-B27 negative lymphocytes obtained from healthy individuals (Baines et al. 1990 ).
• Amino acid sequence homologies have been identified between the 'QTDRED' sequence motifs present in both HLA-B27 and in the K. pneumoniae nitrogenase reductase enzyme (Schwimmbeck et al. 1987 ).
• Further peptide similarities were also identified between the 'DRED' motif in HLA-B27 and a 'DRDE' amino acid sequence in K. pneumoniae pullulanase enzyme and between 'GxP' sequences in K. pneumoniae pullulanase and type I, III and IV collagens (which are located in the spine and large joints predominantly affected by AS) (Fielder et al. 1995) .
Klebsiella pneumoniae is generally not pathogenic in most individuals unless aspirated, when it can cause severe inflammation in the respiratory tract, particularly in immune-compromised individuals. Alternatively, K. pneumoniae may also infect the urinary tract, biliary tract, wounds or gut lesions. Patients with invasive devices (e.g. urinary catheters or respiratory support equipment) are at an increased risk of infection from contaminated equipment. However, it is generally only when K. pneumoniae interacts with the immune system (usually via gastrointestinal lesions) that it stimulates an immune response (Rashid and Ebringer 2007) . Klebsiella pneumoniae infections can induce the production of anti-QTDRED and anti-DRED HLA-B27 antibodies as well antibodies against collagens I, III and IV. It has been postulated that these antibodies crossreact with self tissue in susceptible individuals, particularly in the spine and in large joints (Rashid and Ebringer 2007) . This antibody binding activates a number of downstream processes including inflammatory cascades involving acute phase proteins, components of complement, vasoactive amines, as well as cytokines, tumour necrosis factor-a (TNF-a) and various other cytotoxic components (Rashid and Ebringer 2007) . Furthermore, this antibody crossreactivity activates further cellular processes, including those involving the action of natural killer cells (Braun and Sieper 2007) . Initial infections often result in mild symptoms. Recurrent infections result in enhanced production of cross-reactive antibodies and intensification of the immunological reactions with ensuing tissue damage.
Many antibiotics are already known to inhibit K. pneumoniae (e.g. aminoglycosides, fluoroquinolones, tetracyclines, chloramphenicol). However, the development of super-resistant bacterial strains has reduced their value for treating many K. pneumoniae infections (Ashayeri-Panah et al. 2014; Nathisuwan et al. 2001 ). The search is ongoing for new antimicrobials, either by 1. design and synthesis of new agents, or 2. re-searching the repertoire of natural resources for as yet unrecognised or poorly characterised antimicrobial agents. The antiseptic qualities of medicinal plants have long been recognised by many cultures. Recently there has been a revival of interest in herbal medications due to perceptions that there is often a lower incidence of adverse reactions to natural endobiotic phytochemicals compared to synthetic xenobiotic pharmaceuticals.
In a previous study examining the potential of South African plants to prevent and treat rheumatoid arthritis (Cock and van Vuuren 2014) , several South African plant species were identified which have been traditionally used for the treatment of various inflammatory disorders. Therefore, a study was designed to 1. examine the same panel of Southern African medicinal plant species for their in vitro efficacy against the bacterial trigger of AS (K. pneumoniae) and 2. evaluate the toxicity of the plant extracts in vivo.
Materials and methods

Ethnobotanical information
Several literature resources were utilised to identify Southern African plants with a history of usage in the treatment of rheumatism and other inflammatory disorders for a previous study (Cock and van Vuuren 2014) . The same species were also examined in this study.
Plant collection and extraction
The majority of the plant species were collected from the Walter Sisulu Botanical Gardens in Johannesburg, South Africa (SA). Syzygium cordatum and Lippia javanica were obtained from Maputaland (KwaZulu-Natal, SA) and Agathosma betulina was collected from Landmeterskop (Southern Cape, SA). All plants were identified by Andrew Hankey, chief botanist at the Walter Sisulu Botanical Gardens in Johannesburg, SA, or respective authorities in the other provinces. Voucher specimens were prepared and are stored at the Department of Pharmacy and Pharmacology, University of Witwatersrand, Johannesburg, SA. All plant materials were air dried and ground into a fine powder.
Extracts (1 g coarsely ground plant material) were prepared by adding either 50 ml of AR grade methanol or 50 ml distilled water. Plant material was extracted in each solvent for 24 h at 4°C with gentle shaking. The extracts were filtered through filter paper (Whatman No. 54) . The methanol extracts were subsequently allowed to dry at room temperature. The aqueous extracts were frozen at -70°C and dried by lyophilisation. These dried extracts were then weighed and redissolved in 10 ml deionised water.
Antibacterial screening
Test micro-organisms A reference strain of K. pneumoniae (ATCC 13883) was obtained from American Tissue Culture Collection (ATCC) and subcultured and maintained in nutrient broth (Oxoid Ltd, UK) at 4°C.
Evaluation of antimicrobial activity
Antimicrobial activity of all plant extracts was determined using a modified disc diffusion method (Cock 2009; Cock and Mohanty 2011) . Briefly, 100 ll of the test bacteria were grown in 10 ml of fresh nutrient broth until they reached a count of approximately 10 8 cells/ml. One hundred microlitres of this microbial suspension was spread onto nutrient agar plates.
The extracts were tested using 5 mm sterilised filter paper discs impregnated with 10 ll of the test sample, then allowed to dry and placed onto inoculated plates. The plates were allowed to stand at 4°C for 2 h, allowing for prediffusion of the extract into the agar before incubation with the test microbial agents. The plates were incubated at 30°C for 24 h, and then the diameters of the inhibition zones were measured in millimetres. All measurements were to the closest whole millimetre. Each antimicrobial assay was performed at least in triplicate and mean values were determined. Standard discs of ampicillin (2 lg) and chloramphenicol (10 lg) (Oxoid Ltd, UK) served as positive controls for antimicrobial activity. Filter discs impregnated with either 10 ll of distilled water or methanol were used as negative controls.
Minimum inhibitory concentration (MIC) determination
The minimum inhibitory concentration (MIC) of the plant extracts were determined by the disc diffusion MIC method (Cock and Kukkonen 2011; Vesoul and Cock 2011 ) across a range of different concentrations. Briefly, the plant extracts were serially diluted in deionised water across a range of concentrations. Discs were impregnated with 10 ll of the test dilutions, allowed to dry and placed onto inoculated plates. Graphs of the zone of inhibition versus concentration were plotted for each extract. Linear regression was used to calculate the MIC values.
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Toxicity screening
Reference toxin
Potassium dichromate (K 2 Cr 2 O 7 ) (AR grade, Saarchem, South Africa) was prepared as a 1.6 mg/ml solution in distilled water and serially diluted in artificial seawater for use in the A. franciscana nauplii bioassay.
Artemia franciscana (brine shrimp) nauplii toxicity screening
Artemia franciscana cysts were obtained from North American Brine Shrimp, LLC, USA (harvested from the Great Salt Lake, Utah). Artificial seawater was prepared using Reef Salt, AZOO Co., USA. Seawater solutions at 34 g/l distilled water were prepared prior to use. Atremia nauplii were prepared by standard methods (Sautron and Winnett et al. 2014) . Toxicity was tested using a modified A. franciscana nauplii lethality assay (Sirdaarta and Cock 2010; 2008) . Briefly, a volume of 400 ll of seawater containing approximately 37 (mean = 37.2, n = 132, SD = 11.6) nauplii was added to wells within a 48-well plate and immediately used for the bioassay. The plant extracts were first diluted to 4 mg/ml in seawater and then used at a 2 mg/ml concentration in the bioassay. A volume of 400 ll of diluted plant extract and the reference toxin were transferred to the wells and incubated at 25 ± 1°C under artificial light (1000 Lux). A negative control (400 ll seawater) was included in triplicate for each plate. All treatments were performed in at least triplicate. The wells were checked at regular intervals and the number of dead brine shrimp counted. The nauplii were considered moribund if no movement of the appendages was observed within 10 s. After 24 h, all nauplii were sacrificed (by the addition of 50 ll glacial acetic acid) and counted to determine the total number per well. The LC 50 with 95 % confidence limits for each treatment was calculated using Probit analysis.
Reverse-phase high-performance liquid chromatography (RP-HPLC)
Gradient RP-HPLC was performed at a flow rate of 1 mg/ml using a Dionex Ultimate 3000 pump and gradient system, an Ultimate 3000 variable wavelength programmable photodiode array detector (Dionex) and a Phenomenex reverse-phase C 18 column (150 mm 9 4.6 mm). The HPLC system was equipped with Chromeleon software (Dionex). The gradient was constructed as follows: 5 min elution with 5 % acetonitrile, followed by a 30-min gradient to 65 % acetonitrile. The system was then re-equilibrated to 5 % acetonitrile for subsequent chromatograms. The column temperature was maintained at 20°C throughout. Plant extract samples (10 ll) were injected manually. Resveratrol (Sigma) was dissolved in ethanol (AR grade), diluted in deionized water and 10 ll aliquots of various concentrations were injected as a standard to calibrate the HPLC column. Deionised water (10 ll) was used as a negative control to produce the baseline curve and zero the equipment prior to each experiment.
Statistical analysis
Data are expressed as the mean ± SEM of at least three independent experiments.
Results
Liquid extraction yields
Extraction of 1 g of the dried plant materials with methanol and water yielded dried plant extracts with a wide range of masses, from 6 mg (W. salutaris bark water extract) to 284 mg (P. obliquum leaf methanolic extract) ( Table 1) . As a measure of the efficacy of the main forms in which these plants are traditionally used in ethnobotanical medicinal systems (decoctions and tinctures), methanolic and aqueous extracts were tested undiluted for their ability to inhibit the growth of K. pneumoniae. There was no obvious trend with regards to which solvent was more efficient at extracting material from the plant samples. Methanol extracted a greater amount of material for seven of the sixteen plant samples tested (44 %), whereas water extracted the greater amount of material for eight of these samples (50 %). One source provided equal masses of extract with both water and methanol. No obvious correlation was noted between the plant part tested and the amount of extracted material. For two plant species (S. cordatum and W. salutaris), both bark and leaf materials were extracted. Approximately five times as much material was extracted from S. cordatum bark than from its leaves by methanol. Similarly, water extracted twice as much material from the bark than from the leaves. In contrast, much more material was extracted from W. salutaris leaves than from the bark by both methanol and water (approximately eightfold and twofold higher, respectively). With another plant (T. violaceae), leaf and root materials were extracted and tested. Methanol extracted significantly more material from T. violaceae leaves than from the roots. However, water extracted much more material from T. violaceae roots than from the leaves. All dried extracts were resuspended in 10 ml of deionised water, yielding the concentrations shown in Table 1 .
Antibacterial activity
Bacterial growth was susceptible to inhibition by a wide range of plant extracts. Indeed, the only plant materials for which neither the methanol nor water extracts inhibited K. pneumoniae growth were the C. edulis fruit, P. viridiflorum leaf and W. salutaris bark extracts. K. pnuemoniae was inhibited by 26 of the 34 (77 %) extracts tested. Zones of inhibition [10 mm were considered to indicate significant antibiotic activity (Fig. 1) . The most effective species for the inhibition of K. pneumoniae growth was S. cordatum (based on the zones of inhibition). Indeed, methanolic and aqueous extracts of bark and leaf S. cordatum extracts displayed significantly more potent K. pneumoniae growth Fig. 2 The lethality of plant extracts (2,000 lg/ml) and potassium dichromate control (1,000 lg/ml) towards Artemia nauplii after 24 h exposure. All bioassays were performed in triplicate and the mean ± SEM are shown here. 1, A. betulina leaf methanolic extract; 2, A. betulina leaf water extract; 3, B. africana leaf methanolic extract; 4, B. africana leaf water extract; 5, C. edulis leaf methanolic extract; 6, C. edulis leaf water extract; 7, K. africana leaf methanolic extract; 8, K. africana leaf methanolic extract; 9, L. javanica leaf methanolic extract; 10, L. javanica leaf water extract; 11, P. fasiculata leaf methanolic extract; 12, P. fasiculata leaf water extract; 13, P. viridiflorum leaf methanolic extract; 14, P. viridiflorum leaf water extract; 15, P. obliquum leaf methanolic extract; 16, P. inhibition than either of the control antibiotics (ampicillin and chloramphenicol). The S. cordatum bark methanolic extract was a more potent inhibitor of K. pneumoniae growth than was the corresponding aqueous extract with zones of inhibition of 14.3 ± 0.6 and 13.0 ± 0 mm, respectively. In contrast, the aqueous S. cordatum leaf extract was more potent than the corresponding methanolic extract based on the zones of inhibition (13.3 ± 0.6 and 9.4 ± 0.6 mm, respectively.
Terminalia pruinoides and Terminalia sericea methanol extracts (12.7 ± 0.6 and 13.0 ± 0 mm respectively) also were more potent inhibitors of K. pneumoniae growth than were the corresponding aqueous extracts (11.6 ± 0.6 and 12.0 ± 1.0 mm for the T. pruinoides and T. sericea aqueous extracts respectively). The C. edulis leaf methanol (11.7 ± 0.6 mm) and aqueous (10.3 ± 0.6 mm) extracts and the L. javanica methanol extract (11.7 ± 0.6 mm) also displayed promising inhibitory Extracts were dried and resuspended in deionised water. Absorbance was recorded at 305 nm The potential of selected South African plants 29 activity against K. pneumoniae. The A. betulina, B. africana, K. africana, P. fasiculata, T. violaceae (particularly the root extracts) and the W. salutaris leaf extracts were less potent. The relative level of antibacterial activity was further quantified by determining the MIC values for each extract against K. pneumoniae (Table 1 ). The S. cordatum, T. pruinoides and T. sericea extracts were again the most potent inhibitors of K. pneumoniae growth, with MIC values generally between 250 and 500 lg/ml (between 2.5 and 5 lg impregnated into the disc). As these are crude extracts, these MIC values compare favourably with inhibition by the ampicillin and chloramphenicol antibiotic controls (2 and 10 lg, respectively). The C. edulis leaf and L. javanica extracts were also potent growth inhibitors, with MIC values generally below 700 lg/ml.
Interestingly, the P. fasiculata, B. africana, T. violaceae and W. salutaris methanolic and aqueous leaf extracts and the K. africana aqueous extract displayed potent inhibition, with MIC values generally below 700 lg/ml (7 lg impregnated into the disc). The potent inhibitory activities of the extracts seen by MIC determination are in contrast to the lower efficacy seen in the disc diffusion screening. This may indicate that the antimicrobial compounds in these extracts may be either large or of low polarity and, therefore, diffuse less freely in the agar gel. The K. africana methanolic extract and the methanolic and aqueous extracts of A. betulina and P. obliquum also displayed significant growth inhibitory activity towards K. pneumoniae, but were substantially less potent, with MIC values generally [1000 lg/ml.
Quantification of toxicity
The plant extracts were serially diluted in artificial seawater for mortality determination in the Artemia nauplii lethality bioassay. Potassium dichromate (the reference toxin) was also tested in the bioassay for comparison. Figure 2 shows the % mortality induced in this bioassay following 24 of exposure to the reference toxin or the plant extracts. Potassium dichromate rapidly induced mortality within 3 h of exposure (results not shown). After 24 h exposure, potassium dichromate had killed 100 % of the Artemia nauplii. At 24 h, the only extracts to induce mortality significantly above that of the seawater control were the aqueous extracts of P. fasiculata, T. violaceae root and leaf water extracts.
To compare the toxicity of those plant extracts showing significant mortality with other toxins, the LC 50 values of the extracts and the reference toxin were determined by testing across a range of concentrations in the Artemia nauplii bioassay. Table 1 shows the LC 50 values of the extracts which had shown toxicity towards A. franciscana.
Whilst the P. fasiculata leaf water extract initially appeared toxic in the extract mortality screening study (Fig. 2) , determination of its LC 50 demonstrates that it is non-toxic as LC 50 values of C1000 lg/ml have previously been defined as non-toxic in the Artemia nauplii bioassay (Ruebhart et al. 2009; Cock 2008 ). The T. violaceae root and leaf water extracts each displayed 24 h LC50 values of approximately 800 lg/ml, which is considered to be low toxicity.
RP-HPLC analysis of extracts displaying antimicrobial activity
The K. pneumoniae growth inhibition and MIC studies indicated that the B. africana, C. edulis leaf, L. javanica leaf, S. cordatum bark, S. cordatum leaf, T. pruinoides leaf and T. sericea leaf extracts were the most promising extracts for further phytochemical characterisation. These were examined for the presence of trans-3,4,5-trihydroxytrans-stilbene (resveratrol). Resveratrol is a potent phenolic anti-inflammatory antioxidant produced as a phytoalexin (plant antibiotic) by many diverse plant species including grapes, berries, peanuts as well as some species of pine trees, Acacia spp., Terminalia spp. (including T. sericea), orchids and lilies (Joseph et al. 2008) . The methanolic and aqueous extracts of the plant species displaying the most potent K. pneumoniae growth inhibitory activity were further analysed by RP-HPLC chromatography to determine whether they contain resveratrol. However, resveratrol itself did not show K. pneumoniae growth inhibitory activity at levels up to 1000 lg/ml.
The B. africana methanol (Fig. 3a) and aqueous extracts (Fig. 3b) both displayed peaks at the same elution volume as pure resveratrol (Fig. 3c ). An examination of the UV visual spectra of these peaks showed that the spectra were consistent with that of pure resveratrol (Fig. 3d) , with absorption maxima at approximately 216 and 303 nm. However, resveratrol was present as only a minor component in both B. africana extracts.
Similarly, C. edulis and L. javanica leaf methanolic extracts displayed peaks at similar elution volumes and with similar UV visual spectra to pure resveratrol. In contrast to the B. africana extracts, only the C. edulis and L. javanica methanolic extracts (Fig. 4a, c, respectively) showed peaks at similar elution volumes as pure resveratrol. The UV visual spectra of these peaks were consistent with the authentic resveratrol spectra (Fig. 3d) . Resveratrol was not detected in either the C. edulis leaf aqueous extract (Fig. 4b) , or the L. javanica aqueous extract (Fig. 4d) . As the aqueous extracts of both species had similar MIC values as the corresponding methanolic extracts, it is unlikely that resveratrol is solely responsible for the K. pneumoniae inhibitory activity.
None of the S. cordatum extracts (Fig. 5a-d) displayed chromatographic peaks consistent with authentic resveratrol. This is noteworthy as the S. cordatum extracts were amongst the most potent K. pneumoniae growth inhibitors (as judged by the zones of inhibition and MIC analyses). It is evident that resveratrol is not responsible for the direct anti-inflammatory properties, or for the ankylosing spondylitis preventative/K. pneumoniae inhibitory properties of S. cordatum. In contrast, T. pruinoides and T. sericea methanolic and aqueous extracts (Fig. 6a-d) all displayed peaks at the same elution volume and with similar UV-Vis spectra to pure resveratrol. However, as with the B. africana (methanolic and aqueous extracts), C. edulis and L. javanica (methanolic) extracts, resveratrol was a minor component of the Terminalia spp. extracts, with only minor peaks evident.
Discussion
Traditional plant-based medicines have been used for thousands of years by indigenous populations worldwide. Many of these have a rich tradition of herbal medicine and multiple plants have been used to treat inflammation. Whilst numerous plant species (with a history of traditional use in the treatment of inflammatory diseases) have been screened in vitro, the vast majority of these studies have focussed on their ability to inhibit the production of cytokines and other inflammatory mediators. Very few studies have examined the ability of traditional medicinal plants to block the initiation phases of autoimmune inflammatory diseases, including AS. In a recent study we identified a variety of South African plants with traditional uses in the treatment of inflammation and examined their potential in the treatment of rheumatoid arthritis (Cock and van Vuuren 2014) . This study examined the same panel of plants for their antibiotic activity against the microbial trigger (K. pneumoniae), another chronic inflammatory disease (AS). Figure 7 summarises the proposed progression of AS as an inflammatory disease, from the initial pathogenic events through to the symptoms (the numbers in Fig. 7 and in the text below refer to the current and/or proposed treatment targets). Gastrointestinal K. pneumoniae may act as a trigger for AS (Rashid and Ebringer 2007) ; so limiting the burden of gastrointestinal K. pneumoniae (a) would help prevent AS intiation and minimise its downstream effects. Gastrointestinal K. pneumoniae cannot interact with the immune system unless (b) epithelial lesions (or other epithelial interruptions) allow for the production of anti-K. pneumoniae antibodies (Rashid and Ebringer 2007) . Inhibition of any agents causing lesions of the intestine (e.g. Crohn's disease) might also block AS initiation. Blocking the interaction of K. pneumoniae with immunological cells (c) or the subsequent immune response (d) would also reduce the production of self-reactive antibodies and also diminish the later phase of AS pathogenesis and the consequent disease symptoms. However, immunomodulatory therapy should be used with caution as inhibiting the patient's immune capability also exposes the patient to a variety of other infections. Most current AS therapies target the later phase events (e) by blocking the inflammatory cascades or at stages (f and g) as palliatives by decreasing the symptoms of AS (e.g. pain, swelling, heat). Drugs primarily targeting these later events effectively ease patient discomfort, although they do little to control the tissue damage (associated with the self-reactive antibodies). Targeting earlier events prior to the induction of the immune response would not only alleviate the symptoms and discomfort of AS, but would also lessen/prevent the joint damage associated with bacterial initiated chronic inflammation.
A treatment regime targeting the microbial trigger of AS is an attractive prospect as it would be expected to block/ decrease production of self-reactive antibodies linked to disease onset and progression. The results presented here show the ability of a variety of plants used traditionally to treat rheumatism and other inflammatory complaints in Southern Africa to inhibit K. pneumoniae growth when tested in the format used in traditional medicine (i.e. decoctions and tinctures). Further quantification by MIC determination demonstrated the efficacy of these extracts as inhibitors of one possible microbial trigger of AS. Methanol and water extracts of B. africana, C. edulis leaf, L. javanica, P. viridiflorum, S. cordatum leaf and bark, T. pruinoides, T. sericea, T. violaceae roots and leaves and W. salutaris bark were of particular interest where the MIC values of approximately 300 lg/ml for several extracts, i.e. were substantially more potent than the reference antibiotics (ampicillin and chloramphenicol). They are thus worthy of further phytochemical and mechanistic studies. Many of the plant extracts studied here may also affect other inflammatory processes (e.g. cytokine release) and, therefore, may help control AS by pluripotent/multifaceted mechanisms.
Herbal remedies have long been used to alleviate rheumatic complaints in all traditional medicine systems. In many cases, the major anti-inflammatory components of these plants are available in a pure form and already available as anti-inflammatory agents. These compounds include a variety of polyphenolic compounds, of which 3,5,4 0 -trihydroxy-trans-stilbene (resveratrol) has received much recent attention due to its presence in many plants used in the treatment of inflammation and due to its potent anti-inflammatory activity (Elmali et al. 2007; Wang et al. 2006) . Most studies examining the role of resveratrol in the treatment of inflammatory conditions focus on its ability to act as a potent and specific inhibitor of NF-jB activation, the inducer for two major inflammatory cytokines, TFN-a and IL-1b (Elmali et al. 2007) . It is possible that resveratrol may also have other anti-inflammatory effects as it also exhibits antibacterial activity against a variety of bacterial species (Paulo et al. 2010) . Of the plant extracts examined in this study, B. africana (methanol and aqueous extracts), C. edulis leaf (methanol extract), L. javanica (methanol extract) and the methanol and aqueous extracts of both Terminalia species (T. pruinoides and T. sericea) contained resveratrol at comparatively low levels. In contrast, S. cordatum extracts did not contain discernible levels of resveratrol. Significantly, resveratrol did not inhibit the growth of K. pneumoniae in our test systems, even at concentrations up to 1000 lg/ml, i.e. it was not an antibiotic for this micro-organism (personal unpublished results).
However, it is possible that resveratrol may still contribute to the anti-inflammatory activities of these extracts. Resveratrol glycosides may be present and target cells may metabolise these to release resveratrol. 2-[3-Hydroxy-5[(E)-2-(4-hydroxyphenyl) ethenyl] phenoxy]-6-(hydroxymethyl) oxane-3,4,5-triol (piceid) and polydatin are glycosylated stilbenes that have both been shown to block inflammation by decreasing IL-17 production in stimulated human mononuclear cells (Lanzilli et al. 2012 ). These Fig. 7 Schematic representation of the main proposed events leading to the establishment and progression of AS. Only major events are shown. Numbers refer to current and/or proposed targets for the prevention and treatment of AS glycosylated stilbenes may possibly block the later phases of inflammation by similar mechanisms. Another study (Jayatilake et al. 1993) indicated that the antibacterial activity of resveratrol is due to a protein tyrosine kinase activity. These authors also reported that resveratrol glycosides do not have the same bacterial inhibitory activity, indicating that free hydroxyl groups on both phenyl groups are required for antibacterial activity.
Other stilbenes might be present, even if resveratrol is lacking in an extract. Indeed several stilbenes and stilbene glycosides (including resveratrol glycosides) have been identified in T. sericea (Joseph et al. 2008) . A number of other anti-inflammatory stilbenes are found in other plant species. For example, 2,3,4,5-tetrahydroxystilbene-2-O-b-D-glucoside (TSG) inhibits inflammation by suppressing the induction of pro-inflammatory mediators by reducing NF-jB binding to DNA (Huang et al. 2013) . The same study detected TSG in numerous herbs used to treat inflammation in Chinese traditional medicine. Furthermore, nine stilbene and stilbene derivatives isolated from the roots of Cicer spp. (chickpeas) were shown to inhibit bacterial and fungal growth (Aslam et al. 2009 ).
Whilst future studies may detect stilbene compounds in S. cordatum extracts and in other extracts with K. pneumoniae growth inhibitory activity, it is likely that other phytochemical classes also contribute to the anti-inflammatory properties of these extracts. Alkaloids, anthraquionones, flavonoids, polyphenolics, phytosterols, saponins, tannins and terpenes have also been linked with anti-bacterial activity in different plant species and thus may be responsible (at least in part) for the anti-K. pneumoniae activities reported here. The terpenes isomenthone and diosphenol as found in A. betulina are well known for their antimicrobial and urinary tract disinfectant properties (van Wyk et al. 2009 ). S. cordatum extracts contain pentacyclic triterpenoids, phytosterols, proanthrocyanidins and tannins (van Wyk et al. 2009 ), any of which could be responsible for antimicrobial and anti-inflammatory properties. Terminalia spp. and W. salutaris are also high in sesquiterpenoids (including polygodial) and tannins having antibacterial properties (van Wyk et al. 2009 ). Similarly, the volatile oils from L. javanica and Pellargonium spp. are rich in monoterpenoids with strong antibacterial and antiinflammatory properties (van Wyk et al. 2009 ). Furthermore, the oils from Pellargonium spp. are rich in sesquiterpenes and alkaloids. The terpenoid and saponin extracts of P. viridiflorum have both antimicrobial and antiinflammatory activity (van Wyk et al. 2009 ). Several C. edulis and K. africana flavonoids have documented antimicrobial activity (van Wyk et al. 2009 ). Further bioactivity-guided separation studies are recommended to identify the anti-K. pneumoniae compounds in these plant extracts.
The findings reported here also demonstrate that the majority of extracts tested were non-toxic in the Artemia nauplii bioassay. Only the P. fasiculata leaf water extract and the T. violaceae root and leaf water extracts induced mortality significantly above that of the negative control. Determination of the LC 50 values indicated that only T. violaceae extracts displayed LC 50 values below 1000 lg/ ml. Therefore, all the other active plant extracts can be considered as non-toxic. Compounds with an LC 50 of greater than 1000 lg/ml towards Artemia nauplii have been previously defined as being non-toxic (Ruebhart et al. 2009 ). Even the T. violaceae root and leaf water extracts (with LC 50 values [700 lg/ml) are considered low in toxicity. It was, therefore, determined that all extracts tested here were either non-toxic or of low toxicity.
Conclusions
The antimicrobial efficacies of these plants against the pathogenic microbe K. pneumoniae help validate the usage of these particular plants in traditional South African medicinal systems, especially to treat autoimmune inflammatory disorders including ankylosing spondylitis and related inflammatory conditions. They also indicate that the phytochemistry and pharmacology of these plants certainly deserve further study, particularly for any other activities associated with the treatment of ankylosing spondylitis (e.g. inhibition of cytokine production). Further toxicity studies using human cell lines are needed to verify the acceptability of the toxicity reported herein should further clinical trials be considered.
